257 related articles for article (PubMed ID: 9858531)
1. RING1 interacts with multiple Polycomb-group proteins and displays tumorigenic activity.
Satijn DP; Otte AP
Mol Cell Biol; 1999 Jan; 19(1):57-68. PubMed ID: 9858531
[TBL] [Abstract][Full Text] [Related]
2. Polycomb-group oncogenes EZH2, BMI1, and RING1 are overexpressed in prostate cancer with adverse pathologic and clinical features.
van Leenders GJ; Dukers D; Hessels D; van den Kieboom SW; Hulsbergen CA; Witjes JA; Otte AP; Meijer CJ; Raaphorst FM
Eur Urol; 2007 Aug; 52(2):455-63. PubMed ID: 17134822
[TBL] [Abstract][Full Text] [Related]
3. HPC3 is a new human polycomb orthologue that interacts and associates with RING1 and Bmi1 and has transcriptional repression properties.
Bárdos JI; Saurin AJ; Tissot C; Duprez E; Freemont PS
J Biol Chem; 2000 Sep; 275(37):28785-92. PubMed ID: 10825164
[TBL] [Abstract][Full Text] [Related]
4. RING1 is associated with the polycomb group protein complex and acts as a transcriptional repressor.
Satijn DP; Gunster MJ; van der Vlag J; Hamer KM; Schul W; Alkema MJ; Saurin AJ; Freemont PS; van Driel R; Otte AP
Mol Cell Biol; 1997 Jul; 17(7):4105-13. PubMed ID: 9199346
[TBL] [Abstract][Full Text] [Related]
5. Interaction proteomics analysis of polycomb proteins defines distinct PRC1 complexes in mammalian cells.
Vandamme J; Völkel P; Rosnoblet C; Le Faou P; Angrand PO
Mol Cell Proteomics; 2011 Apr; 10(4):M110.002642. PubMed ID: 21282530
[TBL] [Abstract][Full Text] [Related]
6. Polycomb group gene silencing proteins are concentrated in the perichromatin compartment of the mammalian nucleus.
Cmarko D; Verschure PJ; Otte AP; van Driel R; Fakan S
J Cell Sci; 2003 Jan; 116(Pt 2):335-43. PubMed ID: 12482919
[TBL] [Abstract][Full Text] [Related]
7. The polycomb protein MPc3 interacts with AF9, an MLL fusion partner in t(9;11)(p22;q23) acute leukemias.
Hemenway CS; de Erkenez AC; Gould GC
Oncogene; 2001 Jun; 20(29):3798-805. PubMed ID: 11439343
[TBL] [Abstract][Full Text] [Related]
8. Characterization of interactions between the mammalian polycomb-group proteins Enx1/EZH2 and EED suggests the existence of different mammalian polycomb-group protein complexes.
Sewalt RG; van der Vlag J; Gunster MJ; Hamer KM; den Blaauwen JL; Satijn DP; Hendrix T; van Driel R; Otte AP
Mol Cell Biol; 1998 Jun; 18(6):3586-95. PubMed ID: 9584199
[TBL] [Abstract][Full Text] [Related]
9. Variability in the expression of polycomb proteins in different normal and tumoral tissues. A pilot study using tissue microarrays.
Sánchez-Beato M; Sánchez E; González-Carreró J; Morente M; Díez A; Sánchez-Verde L; Martín MC; Cigudosa JC; Vidal M; Piris MA
Mod Pathol; 2006 May; 19(5):684-94. PubMed ID: 16528373
[TBL] [Abstract][Full Text] [Related]
10. Essential role for activation of the Polycomb group (PcG) protein chromatin silencing pathway in metastatic prostate cancer.
Berezovska OP; Glinskii AB; Yang Z; Li XM; Hoffman RM; Glinsky GV
Cell Cycle; 2006 Aug; 5(16):1886-901. PubMed ID: 16963837
[TBL] [Abstract][Full Text] [Related]
11. RYBP, a new repressor protein that interacts with components of the mammalian Polycomb complex, and with the transcription factor YY1.
García E; Marcos-Gutiérrez C; del Mar Lorente M; Moreno JC; Vidal M
EMBO J; 1999 Jun; 18(12):3404-18. PubMed ID: 10369680
[TBL] [Abstract][Full Text] [Related]
12. Selective interactions between vertebrate polycomb homologs and the SUV39H1 histone lysine methyltransferase suggest that histone H3-K9 methylation contributes to chromosomal targeting of Polycomb group proteins.
Sewalt RG; Lachner M; Vargas M; Hamer KM; den Blaauwen JL; Hendrix T; Melcher M; Schweizer D; Jenuwein T; Otte AP
Mol Cell Biol; 2002 Aug; 22(15):5539-53. PubMed ID: 12101246
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of interactions between the vertebrate polycomb-group protein BMI1 and human homologs of polyhomeotic.
Gunster MJ; Satijn DP; Hamer KM; den Blaauwen JL; de Bruijn D; Alkema MJ; van Lohuizen M; van Driel R; Otte AP
Mol Cell Biol; 1997 Apr; 17(4):2326-35. PubMed ID: 9121482
[TBL] [Abstract][Full Text] [Related]
14. The interactions of LIM protein KyoT with polycomb proteins.
Li R; Zhang R
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Feb; 35(2):113-6. PubMed ID: 12545215
[TBL] [Abstract][Full Text] [Related]
15. The Polycomb group protein EZH2 is upregulated in proliferating, cultured human mantle cell lymphoma.
Visser HP; Gunster MJ; Kluin-Nelemans HC; Manders EM; Raaphorst FM; Meijer CJ; Willemze R; Otte AP
Br J Haematol; 2001 Mar; 112(4):950-8. PubMed ID: 11298590
[TBL] [Abstract][Full Text] [Related]
16. A panel of monoclonal antibodies against human polycomb group proteins.
Hamer KM; Sewalt RG; den Blaauwen JL; Hendrix T; Satijn DP; Otte AP
Hybrid Hybridomics; 2002 Aug; 21(4):245-52. PubMed ID: 12193277
[TBL] [Abstract][Full Text] [Related]
17. The polycomb group protein BMI1 is a transcriptional target of HDAC inhibitors.
Bommi PV; Dimri M; Sahasrabuddhe AA; Khandekar J; Dimri GP
Cell Cycle; 2010 Jul; 9(13):2663-73. PubMed ID: 20543557
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of the EZH2, RING1 and BMI1 genes is common in myelodysplastic syndromes: relation to adverse epigenetic alteration and poor prognostic scoring.
Xu F; Li X; Wu L; Zhang Q; Yang R; Yang Y; Zhang Z; He Q; Chang C
Ann Hematol; 2011 Jun; 90(6):643-53. PubMed ID: 21125401
[TBL] [Abstract][Full Text] [Related]
19. C-Terminal binding protein is a transcriptional repressor that interacts with a specific class of vertebrate Polycomb proteins.
Sewalt RG; Gunster MJ; van der Vlag J; Satijn DP; Otte AP
Mol Cell Biol; 1999 Jan; 19(1):777-87. PubMed ID: 9858600
[TBL] [Abstract][Full Text] [Related]
20. Interference with the expression of a novel human polycomb protein, hPc2, results in cellular transformation and apoptosis.
Satijn DP; Olson DJ; van der Vlag J; Hamer KM; Lambrechts C; Masselink H; Gunster MJ; Sewalt RG; van Driel R; Otte AP
Mol Cell Biol; 1997 Oct; 17(10):6076-86. PubMed ID: 9315667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
